Projektbeschreibung Neurofeedback in children with - Gepris
Transcription
Projektbeschreibung Neurofeedback in children with - Gepris
Neurofeedback in children with attention-deficit/hyperactivity disorder (ADHD) - a controlled multicenter study of a non-pharmacological treatment approach Antragsteller: Professor Dr. Martin Holtmann LWL-Universitätsklinik Bochum Klinik der Ruhr-Universität Bochum Klinik für Kinder- und Jugendpsychiatrie Psychotherapie - Psychosomatik Heithofer Allee 64 59071 Hamm Telefon: +49 2381 8931069 Telefax: +49 2381 8931169 E-Mail: martin.holtmann wkp-lwl.org Fachliche Zuordnung Klinische Neurowissenschaften II - Psychiatrie, Psychotherapie, Kinder- und Jugendspychiatrie Förderung von 2008 bis 2015 Förderung Projektbeschreibung Attention-deficit/hyperactivity disorder (ADHD) is the most common neurobehavioral disorder of childhood. At present, pharmacotherapy like methylphenidate (e.g., Ritalin) is the treatment of choice for ADHD children. Among alternative treatment approaches, Neurofeedback (EEG-Biofeedback) has emerged as a non-invasive treatment for children with ADHD. Neurofeedback refers to a procedure that encourages the individual to exercise a certain amount of self-control over his/her “brainwaves” as recorded by EEG. The rationale for using Neurofeedback as an intervention in ADHD is the consistently reported neurophysiological deficit of cortical arousal in ADHD children. The aim of such training is that the children learn how to bring their neurophysiological profile closer to that of non-ADHD children, resulting in concomitant improvements in behaviour and cognition. The aim of this investigation is to examine the efficacy of Neurofeedback in childhood ADHD in a prospective, randomized, controlled study, assessing its effectiveness in comparison to an unspecific peripheral biofeedback treatment (electromyographic biofeedback) with an identical setting. After a six-month delay, a follow-up examination will be conducted focusing on the long-term effects. DFG-Verfahren Beteiligte Person: Klinische Studien Privatdozentin Dr. Ute Strehl GEPRIS ist ein Projekt der Deutschen Forschungsgemeinschaft. Sie erreichen GEPRIS unter http://www.dfg.de/gepris (c) 1999 - 2017 Deutsche Forschungsgemeinschaft (http://www.dfg.de)